» Articles » PMID: 25573665

PPARγ Deficiency Results in Severe, Accelerated Osteoarthritis Associated with Aberrant MTOR Signalling in the Articular Cartilage

Abstract

Objectives: We have previously shown that peroxisome proliferator-activated receptor gamma (PPARγ), a transcription factor, is essential for the normal growth and development of cartilage. In the present study, we created inducible cartilage-specific PPARγ knockout (KO) mice and subjected these mice to the destabilisation of medial meniscus (DMM) model of osteoarthritis (OA) to elucidate the specific in vivo role of PPARγ in OA pathophysiology. We further investigated the downstream PPARγ signalling pathway responsible for maintaining cartilage homeostasis.

Methods: Inducible cartilage-specific PPARγ KO mice were generated and subjected to DMM model of OA. We also created inducible cartilage-specific PPARγ/mammalian target for rapamycin (mTOR) double KO mice to dissect the PPARγ signalling pathway in OA.

Results: Compared with control mice, PPARγ KO mice exhibit accelerated OA phenotype with increased cartilage degradation, chondrocyte apoptosis, and the overproduction of OA inflammatory/catabolic factors associated with the increased expression of mTOR and the suppression of key autophagy markers. In vitro rescue experiments using PPARγ expression vector reduced mTOR expression, increased expression of autophagy markers and reduced the expression of OA inflammatory/catabolic factors, thus reversing the phenotype of PPARγ KO mice chondrocytes. To dissect the in vivo role of mTOR pathway in PPARγ signalling, we created and subjected PPARγ-mTOR double KO mice to the OA model to see if the genetic deletion of mTOR in PPARγ KO mice (double KO) can rescue the accelerated OA phenotype observed in PPARγ KO mice. Indeed, PPARγ-mTOR double KO mice exhibit significant protection/reversal from OA phenotype.

Significance: PPARγ maintains articular cartilage homeostasis, in part, by regulating mTOR pathway.

Citing Articles

SIRT3-PINK1-PKM2 axis prevents osteoarthritis via mitochondrial renewal and metabolic switch.

Deng Y, Hou M, Wu Y, Liu Y, Xia X, Yu C Bone Res. 2025; 13(1):36.

PMID: 40087281 DOI: 10.1038/s41413-025-00413-4.


LRP1 mitigates intervertebral disc degeneration by inhibiting endoplasmic reticulum stress through stabilizing the PPARγ.

Yao D, Li M, Zeng W, Wang K, Liao Z, Chen E J Orthop Translat. 2025; 50:196-210.

PMID: 39895867 PMC: 11786795. DOI: 10.1016/j.jot.2024.12.009.


A reciprocal relationship between mitochondria and lipid peroxidation determines the chondrocyte intracellular redox environment.

Hines M, Gomez-Contreras P, Liman S, Wilson A, Lu K, ONeill J Redox Biol. 2024; 75():103306.

PMID: 39133964 PMC: 11366903. DOI: 10.1016/j.redox.2024.103306.


PPARδ agonist protects against osteoarthritis by activating AKT/mTOR signaling pathway-mediated autophagy.

Sun G, Li X, Liu P, Wang Y, Yang C, Zhang S Front Pharmacol. 2024; 15:1336282.

PMID: 38576477 PMC: 10991777. DOI: 10.3389/fphar.2024.1336282.


5-aminosalicylic acid suppresses osteoarthritis through the OSCAR-PPARγ axis.

Kim J, Ryu G, Seo J, Go M, Kim G, Yi S Nat Commun. 2024; 15(1):1024.

PMID: 38310093 PMC: 10838344. DOI: 10.1038/s41467-024-45174-6.


References
1.
Afif H, Benderdour M, Mfuna-Endam L, Martel-Pelletier J, Pelletier J, Duval N . Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes. Arthritis Res Ther. 2007; 9(2):R31. PMC: 1906809. DOI: 10.1186/ar2151. View

2.
Boileau C, Martel-Pelletier J, Fahmi H, Mineau F, Boily M, Pelletier J . The peroxisome proliferator-activated receptor gamma agonist pioglitazone reduces the development of cartilage lesions in an experimental dog model of osteoarthritis: in vivo protective effects mediated through the inhibition of key signaling and.... Arthritis Rheum. 2007; 56(7):2288-98. DOI: 10.1002/art.22726. View

3.
Levine B, Kroemer G . Autophagy in the pathogenesis of disease. Cell. 2008; 132(1):27-42. PMC: 2696814. DOI: 10.1016/j.cell.2007.12.018. View

4.
Mizushima N, Levine B, Cuervo A, Klionsky D . Autophagy fights disease through cellular self-digestion. Nature. 2008; 451(7182):1069-75. PMC: 2670399. DOI: 10.1038/nature06639. View

5.
Lopiccolo J, Blumenthal G, Bernstein W, Dennis P . Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations. Drug Resist Updat. 2008; 11(1-2):32-50. PMC: 2442829. DOI: 10.1016/j.drup.2007.11.003. View